Literature DB >> 18519151

RS3PE presenting in a unilateral pattern: case report and review of the literature.

Robert T Keenan1, Gareen M Hamalian, Michael H Pillinger.   

Abstract

OBJECTIVES: To review the clinical features and pathophysiologic implications of remitting seronegative symmetrical synovitis with pitting edema (RS(3)PE) presenting in a unilateral manner.
METHODS: We identified and characterized an index case of RS(3)PE presenting in a unilateral pattern. We subsequently performed a systematic literature search to identify other reports of patients with unilateral RS(3)PE.
RESULTS: The index case was a 76-year-old male with a prior history of right hemiparesis owing to a cerebrovascular accident 25 years prior, who developed a classic picture of RS(3)PE involving hand (metacarpophalageal and wrist joint) arthritis and dorsal pitting edema, accompanied by an elevated erythrocyte sedimentation rate, but only in the nonhemiparetic hand. The condition responded rapidly to low-dose prednisone. Our literature search identified 5 other cases of unilateral RS(3)PE, including 2 presented only in the Italian or German literature. Of the 5 cases, 2 were in patients with preexisting neurologic disease, in which the neurologically affected side was spared. One additional case initially presented as unilateral disease but rapidly progressed to bilaterality. Two cases presented in a fully unilateral manner despite no reported neurologic abnormalities on the unaffected sides.
CONCLUSIONS: While RS(3)PE is almost always a symmetric disease of the upper extremities, it may rarely present in a unilateral fashion. The apparent ability of neuropathic changes to protect against the expression of RS(3)PE in an extremity suggests a role for neural and possibly other local factors in the genesis/modulation of the onset or maintenance of RS(3)PE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519151     DOI: 10.1016/j.semarthrit.2008.03.008

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  6 in total

Review 1.  RS3PE: Clinical and Research Development.

Authors:  Hongbin Li; Roy D Altman; Qingping Yao
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

2.  RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer.

Authors:  Sang T Kim; William A Murphy; Ana Aparicio; Sumit K Subudhi
Journal:  J Immunother Precis Oncol       Date:  2020-05-14

3.  Syndrome of remitting seronegative symmetrical synovitis with pitting edema: a case series.

Authors:  A N Varshney; N K Singh
Journal:  J Postgrad Med       Date:  2015 Jan-Mar       Impact factor: 1.476

4.  RS3PE syndrome developing during the course of probable toxic shock syndrome: a case report.

Authors:  Moe Kyotani; Tsuneaki Kenzaka; Ryo Nishio; Hozuka Akita
Journal:  BMC Infect Dis       Date:  2018-04-13       Impact factor: 3.090

5.  Unilateral RS3PE in a Patient of Seronegative Rheumatoid Arthritis.

Authors:  Ankur Nandan Varshney; Nilesh Kumar; Ashutosh Tiwari; Ravi Anand; Sashi Ranjan Prasad; Arvind Anand; Abhinandan Mishra; N K Singh
Journal:  Case Rep Rheumatol       Date:  2013-04-10

6.  The Relationship between Remitting Seronegative Symmetrical Synovitis with Pitting Edema and Vascular Endothelial Growth Factor and Matrix Metalloproteinase 3.

Authors:  Tsuneaki Kenzaka
Journal:  Intern Med       Date:  2020-01-17       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.